Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2000
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071138A2 Oral administration of lactobacillus for the maintenance of health in women
11/30/2000WO2000071134A1 Isophosphoramide mustard analogs and use thereof
11/30/2000WO2000047559A3 5-ht1f agonists
11/30/2000WO2000044900A3 Nucleic-acid binding proteins
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000034481A3 DRUG TARGETS IN $i(CANDIDA ALBICANS)
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000021511A3 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2374937A1 Oral administration of lactobacillus for the maintenance of health in women
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1054981A2 Prostate-associated serine protease
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054675A1 Regulation of estrus and ovulation in gilts
11/29/2000EP1054669A2 Use of thiadiazolo[4,3-a]pyridine derivatives
11/29/2000EP1054594A1 Inotropic and diuretic effects of exendin and glp-1
11/29/2000EP1001788A4 Boron carbohydrate complexes and uses thereof
11/29/2000CN1275124A Phthalazine derivatives and remedies for erectile dysfunction
11/29/2000CN1275076A Method of administering liposomal encapsulated taxane
11/29/2000CN1058964C Branched-amino-sbustituted thiazoles, process for their preparation and the pharmaceutical compositions which contain them
11/29/2000CN1058897C Agentia for improving genitality and producing process thereof
11/29/2000CN1058895C Concentrated traditional Chinese medicinal oral liquor or granule for treating dysmenorrhea and irregular menstruation
11/29/2000CN1058893C Medicine for treating woman's dysmenorrhea and preparing process thereof
11/29/2000CN1058879C Cistanche deserticola wine
11/28/2000US6153768 Benzopyran derivatives
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
11/28/2000US6153655 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/28/2000US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis
11/28/2000US6153587 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
11/28/2000US6153581 Drug for recovering renal function
11/28/2000US6153216 Transdermal estradiol/progestogen agent patch and its production
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309434A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000069859A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069472A2 Enzyme-activated anti-tumor prodrug compounds
11/23/2000WO2000069469A1 Topical compositions for prostaglandin e1 delivery
11/23/2000WO2000069449A2 Conditioned cell culture medium compositions and methods of use
11/23/2000WO2000069416A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000WO2000069255A1 Anti-inflammatory therapy for inflammatory mediated infection
11/23/2000WO2000016764A3 Pharmaceutical compositions comprising derivatives of sulphur acids
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2372044A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000CA2371551A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives
11/23/2000CA2370245A1 Enzyme-activated anti-tumor prodrug compounds
11/23/2000CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000CA2368593A1 Anti-inflammatory therapy for inflammatory mediated infection
11/22/2000EP1053323A2 Human receptor proteins
11/22/2000EP1053233A1 Hydroxamic and carboxylic acid derivatives
11/22/2000EP1053007A2 Methods and compositions for modulating leptin activity
11/22/2000EP1052997A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
11/22/2000EP1052993A1 Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunction
11/22/2000EP1052982A1 AMINOTETRALINS AS 5-HT 1D$g(a)? AGONISTS
11/22/2000EP1052980A1 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/22/2000CN1273841A Chinese-herbal medicine for curing mastopathy
11/22/2000CN1273836A Fumaitong liquid and its preparing process
11/22/2000CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same
11/22/2000CN1058708C Quinolone derivative for treatment of urinary incontinence, its prepn. method and application
11/22/2000CN1058630C Chinese drugs for curing male sexual dys-function and its preparing tech.
11/22/2000CN1058617C Cockscomb beverage
11/21/2000US6150526 Piperidine derivative having renin inhibiting activity
11/21/2000US6150389 Antidepressants; treating elevated intraocular pressure, e.g., glaucoma; antidiabetic agents for non-insulin dependent diabetes, sexual disorders, e.g., male impotence and obesity; e.g. trans-2-(3-phenyl-bicyclo(2.2.1)heptyl)-2-aminooxazoline
11/21/2000US6150376 Bi- and tri-cyclic aza compounds and their uses
11/21/2000US6150375 Inhibitors of both of the human 5ar isozymes; benign prostate hyperplasia, male pattern baldness, acne vulgaris, seborrhea, androgenic alopecia, hirsutism and prostate cancer; blocks the conversion of testosterone to 5-alpha-dihydrotestosterone
11/21/2000US6150352 Antagonists of gonadotropin releasing hormone
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150338 Delivery and expression of a recombinant vector containing a dna sequence encoding a protein involved in the regulation of smooth muscle tone into a smooth muscle cell
11/21/2000US6150325 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000068245A1 14β-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS
11/16/2000WO2000068215A1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
11/16/2000WO2000067788A2 Use of soluble costimulatory molecules to enhance immune responses
11/16/2000WO2000067778A1 Gonadotrophins
11/16/2000WO2000067768A1 Compositions for recovering hypofertility
11/16/2000WO2000067765A1 Composition containing dried roe and yohimbine for treating impotence in men
11/16/2000WO2000067735A2 USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/16/2000WO2000067729A1 Regimen and kit for amelioration of premature ejaculation
11/16/2000WO2000053228A3 Use of niaouli essential oil as transdermal permeation enhancer
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia